XOMA, Ltd. (NASDAQ: XOMA) is focused on the discovery and development of antibodies, one of the most powerful and transformative fields of drug innovation today. By building on its pioneering proprietary pipeline, antibody discovery and development platform, and multiple revenue streams, the company is creating novel human antibody therapeutics that could revolutionize medicine and reshape people’s lives. For further information, visit the Company’s web site at www.xoma.com.
- 17 years ago
QualityStocks
XOMA, Ltd. (NASDAQ: XOMA)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – BluSky AI Inc. (OTC: BSAI) Launches SkyMod Series for Scalable, Rapid-Deploy AI Datacenters
BluSky AI (OTC: BSAI) announced the completion of its modular AI datacenter infrastructure, unveiling the…
-
Newton Golf Company Inc. (NASDAQ: NWTG) Unveils Lighter Shaft amid Women’s Golf Boom
Women make up roughly 28% of on-course golfers in the United States, a historic high.…
-
Soligenix Inc. (NASDAQ: SNGX) Makes Advancement in Proprietary Treatment for Behçet’s Disease
Behçet’s disease is more prevalent in countries along the Silk Road, including Türkiye, Iran and…